Prolonged propofol infusion for mechanically ventilated children

Area of Science:

• Pediatric Critical Care Medicine
• Pharmacology
• Respiratory Therapy

Background:

• Sedation is crucial for mechanically ventilated children.
• Midazolam and propofol are common sedative agents.
• Comparative effectiveness data for these agents in pediatric ventilation is limited.

Purpose of the Study:

• To compare 30-day mortality and duration of mechanical ventilation between midazolam and propofol in pediatric patients.
• To evaluate the impact of sedative choice on mechanical ventilation weaning in children.

Main Methods:

• Retrospective analysis of 8016 children requiring mechanical ventilation for ≥3 days.
• Propensity score matching was used to compare outcomes between midazolam (n=7716) and propofol (n=300) groups.
• Key outcomes assessed were 30-day mortality and time to liberation from mechanical ventilation.

Main Results:

• Propensity-matched analysis included 263 pairs of children.
• 30-day mortality was similar between midazolam (6.5%) and propofol (9.1%) groups (p=0.26).
• Weaning from mechanical ventilation was significantly slower in children sedated with midazolam compared to propofol (SHR 1.43, p<0.001).

Conclusions:

• Midazolam and propofol demonstrate comparable 30-day mortality in pediatric patients requiring prolonged mechanical ventilation.
• Midazolam sedation is associated with a prolonged duration of mechanical ventilation and slower weaning compared to propofol.
• These findings suggest propofol may be a preferable sedative agent when faster liberation from mechanical ventilation is desired in pediatric intensive care settings.